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Abstract After incubation of human monocytes J96 and human 
myeloid leukemia HL60 cells with interferons (IFN) c~ or 7, the 
Ap3A concentration considerably increases in parallel with 
accumulation of tryptophanyl-tRNA synthetase (TrpRS, EC 
6.1.1.2) The Ap3A formation in response to IFNs is catalysed by 
an excessive amount of TrpRS. Although the Ap3A function still 
remain unknown its accumulation may imply the Ap3A involment 
in the IFN-signalling pathway. 
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1. Introduction 
Interferons are a family of regulator proteins that bind to 
surface receptors of responsive cells inducing an antiviral and 
antiproliferative states and a variety of immune responses [1 
3]. Induction of gene transcription is an essential part of the 
cellular response to IFNs. Promoters of the IFN-responsive 
genes contain specific DNA sequences termed ISRE and GAS 
[4,5]. One of the genes stimulated by IFNs is a tryptophanyl- 
tRNA synthetase (TrpRS, EC 6.1.1.2), the enzyme involved in 
protein synthesis [6]. The amino acid sequence and the exon- 
intron organisation of the TrpRS gene are known [7,8]. The 
gene contains in the 5'-regulatory region the ISRE and GAS 
elements [8] and TrpRS is induced by IFNs ct and 7 in cul- 
tured cells [9 11]. Contrary to the majority of the aminoacyl- 
tRNA synthetases, mammalian TrpRS in a wide range of the 
in vitro reaction conditions is unable to catalyse diadenosine 
tetraphosphate (Ap4A) synthesis [12]. 
However, in the presence of L-Trp, ATP-Mg 2+ and ADP 
the TrpRS catalyzes the Ap3A formation [12]. Based on the 
above data, it was suggested that accumulation of TrpRS in 
response to IFNs may cause an alteration of the Ap4A/Ap4A 
ratio [13]. 
The objective of this work was to obtain an evidence of 
Ap3A accumulation in response to IFNs ct and 5, action on 
cultured human cells and to show that the increase of the 
Ap3A level is due to the TrpRS induction in IFN-treated cells. 
2. Experimental 
The human monocytes J96 and human myeloid leukemia HE60 cells 
were grown on MEM and RPMI 1640 media, respectively, with 10% of 
fetal calf serum and penicillin (100 IU/ml). Before addition of IFNc~ 
(1000 IU/ml) or IFN 7 (100 IU/ml), cells were grown 24 h with 
[32p]orthophosphate (50/aCi/ml). For extraction of diadenosine oligo- 
phosphates, 10% ice-cold percloric acid was mixed with (25 30) 106 cells. 
After 10 min on ice with gentle shaking, the mixture was centri- 
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fuged 10 min at 1000xg and the supernatant was neutralized with 5 M 
K2CO3. The pellet was discarded and the neutralized extracts were 
treated with E. coli alkaline phosphatase (1.25 gg/ml in 25 mM Tris 
HC1, pH 8.0 and 10 mM MgC12) 3 h at 37°C. After 4-fold dilution 
with water, the extract was applied to a DEAE-cellulose column 
(0.8x10 cm) and nucleotides were eluted with a linear 0.2-0.8 M 
gradient of NH4HCO3, pH 8.2 (12 ml/h). 
Thin-layer chromatography of ApnA was performed on Silufol 
(Kavaler, Czechoslovakia) nd PEI-cellulose (Merck, Germany) plates 
with isoproponol/ammonia/water (7 : 3 :1, v/v/v and 0.85 M LiC1, pH 
4.2, respectively. For autoradiography, the dried plates were kept in 
contact with X-ray film (Kodak X-Omit AR) for 48 h. In order to 
estimate the amount of the labeled nucleotides, the correspondent 
areas were removed from plates and counted in the toluene scintilla- 
tion liquid on SL-30 (Intertechnique, France) counter. 
The TrpRS activity in cell extract was measured as described earlier 
[14]. 20 gl of cell lysate (protein concentration 5 my/ml) was incubated 
with 80 gl of 20 mM Tris-HC1, pH 7.5, 10 mM MgC12, 30 mM KC1, 
0.1 mM dithiotreitol, 2.5 mM ATP, 30 gg of total yeast RNA, 8 IaM 
[a'~C]Trp for 3 min at 37°C. The radioactivity was measured in TCA- 
insoluble fraction. 
Ap3A synthesis in cell extract was measured as described earlier 
[121. 
3. Results 
3.1. TrpRS activity in human cultured cell extracts 
We measured the TrpRS activity in cells extracts prepared 
from untreated and IFNa/7-treated human monocytes J96. It 
appeared that after 24-h incubation with I FNa  the TrpRS 
activity increased 5.5-fold. The 24-h incubation with IFN 7 
had no effect, but after 36 h the TrpRS activity increased 
2.7-fold and after 48 h 1.8-fold (Fig. 1, 1-5). 
We also measured the TrpRS activity in human myeloid 
leukemia HL60 cell extracts. The TrpRS activity in the 
IFN-untreated (control) cells was higher than that in the 
J96 cells (115 pmol/mg protein and 74 pmol/mg protein, re- 
spectively). After 22-h incubation with IFNc~, the TrpRS ac- 
tivity increased 3.6-fold (Fig. 1, 6 and 7). Probably, IFNc~ is 
more efficient inducer of TrpRS in human blood cells than 
IFN 7 at variance with the human fibroblast FS4 cells [10], 
where IFN 7 is a more efficient inducer. 
3.2. Ap3A synthesis in IFN-treated cultured cells 
Human cells were incubated in the presence of I FN~ or 7 
and [32p]orthophosphate. After extraction with percloric acid, 
the acid-soluble fraction was treated with alkaline phospha- 
tase to dephosphorylate he labeled nucleotides, then the mix- 
ture was subjected to chromatography (Fig. 2). The data ob- 
tained demonstrate that the Ap3A concentration in the J96 
cells treated with IFNs significantly increased and reached the 
level of 0.6 pmol/106 cells (for IFNtx) and 0.13 pmol/106 cells 
(for IFN7). 
The Ap3A concentration in HL60 cells, incubated with 
IFNt~ for 15 and 22 h, increased 1.8- and 3.2-fold, respectively 
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Fig. 1. TrpRS activity in J96 (1-5) and HL (6 and 7) cell lysates. 
Control without IFN (1); IFNct, 24 h (2) IFN7:24 h (3), 32 h (4), 
48 h (5), Control (6), IFNa, 22 h (7). 
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(Fig. 3), over the control cells (4.8 pmol/106 cells). In both cell 
lines that have been investigated, the level of Ap4A was con- 
siderably lower (0.46 pmol/106 cells in HL60 cells and 0.05 
pmol/106 cells in J96 cells) than the level of Ap3A. 
The results obtained are comparable with the known data: 
e.g. the Ap4A concentration i human carcinoma A549 was 
0.03 pmol/106 cells [14]. 
3.3. Inhibition of Ap3A synthesis in cell extracts by tryptophan 
analogues 
To ascertain that Ap3A formation is catalysed by an exces- 
sive amount of TrpRS the cell extracts prepared from un- 
treated and IFN-treated J96 and HL60 cells were incubated 
with [~-3zP]ATP as described in [12] in the presence of tryp- 
tamine (10 Ki, 6.10 -4 M, data not shown) or [3-indolilpyruvic 
acid (3 and 10 Ki, 1.5-10 -z M and 5.10 a M, respectively) 
the competitive inhibitors of TrpRS preventing tryptophanyl 
adenylate formation [14]. The data obtained demonstrated 
that the level of Ap3A considerably decreased (Fig. 4) in the 
presence of tryptophan analogues: consequently, the Ap3A 
accumulation results from the TrpRS activity. 
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Fig. 3. ApnA synthesis in HL60 cells. TLC of labeled nucleotides 
on Silufol plates. IFNc~: 15 h (1); 22 h (3). Control (2 and 4). 
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Fig. 2. Ap,,A synthesis in J96 cells. TCL of labeled nucleotides ex- 
tracted from IFN-treated cells on Silufol plates. Control (1), IFNot, 
24 h (2) IFNy: 24 h (3); 32 H (4); 48 h (5). 
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Fig. 4. ApnA synthesis in IFN-treated HL60 cell lysates in the pre- 
sence of 13-indolylpyruvic a id. IFNc~, 24 h (1) Control, without 
IFN (4). IFNot, ~-indolylpyruvic a id (3 Ki) (2). IFNo~, ]~-indolyl- 
pyruvic acid (10 Ki) (3). 
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4. Discussion 
After incubation of cell extracts with IFN~ or 7, the TrpRS 
activity significantly increased in human J96 and HL60 cells 
(Fig. 1). We have shown that this IFN-induced accumulation 
of the enzyme is accompanied by a parallel accumulation of 
Ap3A (Fig. 2 and 3), a cellular substrate identified long ago 
but still with unknown function [15,16]. This observation 
points to the coupling between the IFN~ 7 action and the 
Ap3A function not discussed before in the literature. The 
Ap3A accumulation in cells could be related to cell growth 
retardation induced by IFNs. This possibility could be exam- 
ined by measuring the Ap3A/Ap4A ratio in cell cultures before 
and after the IFN treatment. The elevated levels of ApIA 
were observed in cell-contact growth-inhibited cells [16]. We 
failed to measure the Ap3A/Ap4A ratio in the J96 cells be- 
cause of very low Ap4A concentration, but in the HL60 cells 
the Ap3A/Ap4A ratio increased about 3× in response to 
IFNc~. Some data available in the literature indirectly confirm 
our observation. In several mammalian primary cultures, the 
Ap4A concentration was insignificantly changed upon mito- 
genic stimulation by growth factors, although protein and 
DNA syntheses manifested an active proliferation [17]. The 
Ap4A concentration was not changed under conditions lead- 
ing to a cellular death [17]. The highest Ap4A concentration 
(28 BM) was reported for sperm, which is composed of com- 
pletely quiescent cells [18]. 
It is also possible that the high level of Ap:~A induced by 
IFNs stimulates the transcription of several genes. Finally, the 
Ap3A function could be mediated via interaction with pro- 
teins and, therefore, it may be interesting to look for Ap:~A- 
binding protein(s). The occurrence in cells of Ap3A-specific 
hydrolase indirectly points to some biological role for Ap:~A 
[191. 
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